免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

點尖科學可卡因代謝物酵素免疫分析

K 號:K191638 · 2020-03-12

申請人Medtest DX
決定日期2020-03-12
產品代碼DIO
諮詢委員會此醫療器材法規描述涉及FDA、510(k)、PMA、NCT、PMID及相關網址,以下為繁體中文翻譯: 本醫療器材之監管狀態係依據美國食品藥物管理局(FDA)之相關規定,包括510(k)上市前通知及PMA上市前核准程序。相關臨床試驗資訊可參閱NCT編號及PMID文獻編號,詳細資料請見所附網址。
決定相當於

器材摘要

Pointe Scientific Cocaine Metabolite Enzyme Immunoassay is the device name listed in this FDA 510(k) record. The listed applicant is Medtest DX. It received FDA 510(k) clearance on 2020-03-12 under 510(k) number K191638. The device is classified under product code DIO. It was reviewed by the TX advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the Pointe Scientific Cocaine Metabolite Enzyme Immunoassay?

Pointe Scientific Cocaine Metabolite Enzyme Immunoassay is a medical device that received FDA 510(k) clearance on 2020-03-12. The listed applicant is Medtest DX. The 510(k) number is K191638.

When did Pointe Scientific Cocaine Metabolite Enzyme Immunoassay receive FDA 510(k) clearance?

Pointe Scientific Cocaine Metabolite Enzyme Immunoassay received FDA 510(k) clearance on 2020-03-12, under 510(k) number K191638.

Who is the listed applicant for Pointe Scientific Cocaine Metabolite Enzyme Immunoassay?

The FDA 510(k) record lists Medtest DX as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Pointe Scientific Cocaine Metabolite Enzyme Immunoassay?

The FDA product code for Pointe Scientific Cocaine Metabolite Enzyme Immunoassay is DIO.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

其他以 Medtest DX 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

相關器械(代碼:DIO)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑